These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11043154)

  • 1. The neuropathology of phenylketonuria: human and animal studies.
    Huttenlocher PR
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S102-6. PubMed ID: 11043154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for central nervous system glial cell plasticity in phenylketonuria.
    Dyer CA; Kendler A; Philibotte T; Gardiner P; Cruz J; Levy HL
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):795-814. PubMed ID: 8965095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB/c mice at 9.4 Tesla.
    Kornguth S; Anderson M; Markley JL; Shedlovsky A
    Neuroimage; 1994 Jun; 1(3):220-9. PubMed ID: 9343573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter disturbances in phenylketonuria: Possible underlying mechanisms.
    Ferreira BK; Rodrigues MT; Streck EL; Ferreira GC; Schuck PF
    J Neurosci Res; 2021 Jan; 99(1):349-360. PubMed ID: 32141105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter pathology in phenylketonuria.
    Anderson PJ; Leuzzi V
    Mol Genet Metab; 2010; 99 Suppl 1():S3-9. PubMed ID: 20123467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.
    Kono K; Okano Y; Nakayama K; Hase Y; Minamikawa S; Ozawa N; Yokote H; Inoue Y
    Radiology; 2005 Aug; 236(2):630-6. PubMed ID: 16040919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral glucose metabolism is decreased in white matter changes in patients with phenylketonuria.
    Hasselbalch S; Knudsen GM; Toft PB; Høgh P; Tedeschi E; Holm S; Videbaek C; Henriksen O; Lou HC; Paulson OB
    Pediatr Res; 1996 Jul; 40(1):21-4. PubMed ID: 8798240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP
    J Pediatr; 1995 Aug; 127(2):251-5. PubMed ID: 7636650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylketonuria: MR imaging of the brain with clinical correlation.
    Pearsen KD; Gean-Marton AD; Levy HL; Davis KR
    Radiology; 1990 Nov; 177(2):437-40. PubMed ID: 2217781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria.
    Christ SE; Price MH; Bodner KE; Saville C; Moffitt AJ; Peck D
    Mol Genet Metab; 2016 May; 118(1):3-8. PubMed ID: 26947918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring.
    Levy HL; Lobbregt D; Barnes PD; Poussaint TY
    J Pediatr; 1996 Jun; 128(6):770-5. PubMed ID: 8648535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
    Winn SR; Scherer T; Thöny B; Ying M; Martinez A; Weber S; Raber J; Harding CO
    Mol Genet Metab; 2018 Jan; 123(1):6-20. PubMed ID: 29331172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging.
    Bick U; Fahrendorf G; Ludolph AC; Vassallo P; Weglage J; Ullrich K
    Eur J Pediatr; 1991 Jan; 150(3):185-9. PubMed ID: 2044589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylketonuria-related synaptic changes in a BTBR-Pah(enu2) mouse model.
    Liang L; Gu X; Lu L; Li D; Zhang X
    Neuroreport; 2011 Aug; 22(12):617-22. PubMed ID: 21734610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylketonuria: Direct and indirect effects of phenylalanine.
    Schlegel G; Scholz R; Ullrich K; Santer R; Rune GM
    Exp Neurol; 2016 Jul; 281():28-36. PubMed ID: 27091224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice.
    Embury JE; Charron CE; Martynyuk A; Zori AG; Liu B; Ali SF; Rowland NE; Laipis PJ
    Brain Res; 2007 Jan; 1127(1):136-50. PubMed ID: 17112485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).
    Goldfinger M; Zeile WL; Corado CR; O'Neill CA; Tsuruda LS; Laipis PJ; Cooper JD
    Mol Genet Metab; 2017 Sep; 122(1-2):33-35. PubMed ID: 28506393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.